Meningioma malignant – Basic Information

Go back

Malignant meningioma, also known as Grade III or anaplastic meningioma, is a rare and aggressive form of tumor that grows from the protective membranes surrounding the brain and spinal cord. While most meningiomas develop slowly and remain benign, malignant meningiomas grow rapidly, spread quickly, and present serious challenges for treatment and recovery.

Understanding Malignant Meningioma

Meningiomas develop from the meninges, which are three thin layers of tissue that wrap around and protect your brain and spinal cord. Think of these layers as a protective cushion that keeps your brain safe inside your skull. Most meningiomas are harmless and grow very slowly over many years. However, malignant meningiomas behave very differently.[1]

These tumors are classified as Grade III or anaplastic meningiomas, meaning they contain irregular, abnormal cells that multiply quickly. Unlike their benign counterparts, malignant meningiomas are cancerous and have a tendency to invade surrounding brain tissue or even spread to other organs in the body. This aggressive behavior makes them particularly dangerous and difficult to treat.[3]

Fortunately, malignant meningiomas are quite rare. They represent less than three percent of all meningiomas. The vast majority of meningiomas fall into Grade I, which grow slowly and are noncancerous. Grade II meningiomas, called atypical, grow somewhat faster and have a higher chance of returning after treatment but are still not cancerous. Only the Grade III variety is truly malignant.[1][6]

⚠️ Important
Grade III meningiomas are fast-growing tumors with irregular cells. They are likely to invade brain tissue or spread to other parts of the body. This makes them fundamentally different from Grade I and Grade II meningiomas, which do not spread and are not considered cancerous.

How Common Are Malignant Meningiomas?

Overall, meningiomas are the most frequently diagnosed type of primary brain tumor, accounting for about one-third to more than one-third of all brain tumors. Each year, more than 39,000 Americans receive a meningioma diagnosis. However, the vast majority of these cases are benign tumors that grow slowly and may never cause serious problems.[5][8]

When we focus specifically on malignant meningiomas, the numbers become much smaller. As of recent estimates, approximately 3,360 people in the United States are living with high-grade meningiomas, which include both Grade II and Grade III tumors. This small number reflects how uncommon these aggressive tumors truly are.[3]

The pattern of who develops malignant meningiomas differs somewhat from benign forms. While Grade I meningiomas occur more frequently in women, Grades II and III are more common in men. High-grade meningiomas appear most frequently in non-Hispanic white populations. These aggressive tumors tend to occur in people around 60 years old, and the risk increases with advancing age.[3][10]

Benign meningiomas are found more often in middle-aged women and become more common after age 65. They are also more prevalent in Black individuals. However, when it comes to the malignant variety, males face a higher risk. This gender difference in tumor grade is an important distinction that researchers continue to study.[1][11]

What Causes Malignant Meningiomas?

The exact cause of malignant meningiomas remains largely unknown. Most cases occur randomly, without a clear trigger or explanation. However, scientists have identified that cancer is fundamentally a genetic disease, caused by changes to genes that control how cells function. In the case of meningiomas, these genetic mutations affect the cells of the meninges.[3]

Most meningiomas develop because of something called a chromosomal deletion. This is a genetic mutation where a part of a chromosome, which is the structure that carries our genetic information, goes missing. These deletions can happen spontaneously during a person’s lifetime, or they can be inherited as part of certain genetic conditions that run in families.[1]

Several rare genetic conditions increase the likelihood of developing meningiomas, including malignant forms. These include Neurofibromatosis type 2, which is the most commonly associated condition, as well as Cowden syndrome, Li-Fraumeni syndrome, Multiple endocrine neoplasia type 1, and Von Hippel-Lindau disease. People born with these conditions carry genetic mutations from birth that make them more vulnerable to developing meningiomas throughout their lives.[1][3]

One well-established environmental cause is exposure to radiation, especially during childhood. People who received radiation therapy to the head or brain area, particularly at a young age, face an increased risk of developing meningiomas later in life. The radiation can damage the DNA in meningeal cells, setting the stage for tumor development years or even decades later.[3][7]

Risk Factors for Developing Malignant Meningiomas

While malignant meningiomas can affect anyone, certain factors increase the likelihood of developing these tumors. Understanding these risk factors helps doctors identify people who may need closer monitoring, although having risk factors does not mean a person will definitely develop the disease.

Age plays a significant role. People over 65 years old face a higher risk of developing meningiomas in general, and high-grade tumors tend to appear around age 60. As we age, the accumulated effects of genetic mutations and environmental exposures may contribute to tumor formation.[3][10]

Previous radiation exposure to the head creates a substantial risk. This includes radiation therapy received for other medical conditions, particularly during childhood when developing tissues are more vulnerable to radiation damage. Even several decades after radiation exposure, the risk remains elevated.[7]

Having a biological relative with a meningioma increases your risk, suggesting that genetic factors play a role beyond the rare genetic syndromes mentioned earlier. A family history of meningiomas should prompt awareness and potentially earlier screening if symptoms develop.[1]

Certain hormonal factors have been linked to meningioma development, though this connection is stronger for benign forms. Meningioma cells often express receptors for progesterone, estrogen, and androgens on their surface, suggesting these hormones may influence tumor growth. Women using hormone replacement therapy or birth control pills, as well as those with a history of breast cancer, may face increased risk, though these factors appear less directly connected to malignant forms specifically.[1][7]

Environmental factors such as obesity and alcohol use have also been associated with increased meningioma risk in some studies, though the mechanisms remain unclear. These lifestyle factors may influence overall cancer risk through multiple pathways affecting cellular health and immune function.[7]

Recognizing the Symptoms

The symptoms of malignant meningiomas depend heavily on where the tumor grows within the brain or spinal cord. Because these tumors develop on the surface of the brain rather than within the brain tissue itself, they cause problems by pressing against and compressing nearby structures. The specific symptoms reflect which area of the brain is being affected.[3]

Malignant meningiomas grow faster than benign ones, which means symptoms may appear more quickly and worsen more rapidly. However, many symptoms can still develop gradually, making them easy to overlook initially or mistake for other, less serious conditions.[1]

Headaches represent one of the most common symptoms. These headaches often feel worse in the morning and may progressively worsen over time. Unlike ordinary headaches that come and go, brain tumor headaches tend to be persistent and may not respond well to typical pain relievers.[2][3]

Vision problems can occur if the tumor presses on the optic nerve or affects areas of the brain responsible for processing visual information. People may experience blurred vision, double vision, or even partial vision loss. In some cases, the eyes may appear to bulge forward as the tumor grows behind them.[1][2]

Hearing changes are another possible symptom, particularly ringing in the ears or progressive hearing loss. These symptoms suggest the tumor is affecting the auditory nerve or related brain structures. Some people may also lose their sense of smell if the tumor grows near the olfactory nerve, which is responsible for smell.[1][2]

Seizures, which are sudden episodes of abnormal electrical activity in the brain, can occur when the tumor irritates brain tissue. These may be the first sign that something is wrong, especially in someone with no prior history of seizures.[1][3]

Weakness in the arms or legs, muscle problems, or coordination difficulties can develop if the tumor affects areas controlling movement. People might notice they drop things more often, have trouble with balance, or find it harder to perform tasks requiring fine motor control.[1][2]

Memory problems, confusion, personality changes, or difficulty speaking can emerge when tumors affect areas of the brain responsible for these functions. Family members might notice behavioral changes or that their loved one seems different in subtle ways.[1][2]

Because malignant meningiomas can grow quite large if left untreated, severe complications may develop. These can include significant memory loss, paralysis, major personality or behavioral changes, severe speech difficulties, and vision loss. These serious complications underscore the importance of early detection and treatment.[1]

⚠️ Important
Symptoms of meningiomas often begin slowly and may be hard to notice at first. However, if you experience persistent headaches that worsen over time, new seizures, progressive vision or hearing changes, or worsening neurological symptoms, seek medical attention promptly. Sometimes a meningioma requires immediate care, so emergency evaluation may be necessary if symptoms suddenly worsen.

Can Malignant Meningiomas Be Prevented?

Unfortunately, there is no guaranteed way to prevent malignant meningiomas, primarily because the exact cause remains unknown for most cases. However, understanding risk factors can help people make informed decisions about their health and potentially reduce their risk.

Avoiding unnecessary radiation exposure, especially to the head and neck area, is the most concrete preventive step. This includes minimizing medical radiation exposure when possible and ensuring that radiation therapy, when medically necessary, is delivered with precise modern techniques that limit exposure to healthy tissue. However, people should never avoid necessary medical imaging or radiation therapy out of fear, as the benefits typically far outweigh the risks.[3]

For people with genetic conditions known to increase meningioma risk, such as Neurofibromatosis type 2, regular monitoring and screening may help detect tumors early when they are smaller and potentially easier to treat. Genetic counseling can help families understand their risks and make informed decisions about surveillance.[3]

Maintaining overall health through a balanced lifestyle may support general cancer prevention, though no specific diet or lifestyle changes have been proven to prevent meningiomas specifically. Managing obesity and limiting alcohol consumption may reduce risk based on some research findings, though more studies are needed to confirm these associations.[7]

Since malignant meningiomas cannot reliably be prevented, awareness of symptoms and prompt medical attention when concerning signs appear becomes crucial. Early detection often leads to better treatment outcomes, even if the tumor itself could not be prevented.

How Malignant Meningiomas Affect the Body

Understanding what happens inside the body when a malignant meningioma develops helps explain why these tumors cause the symptoms they do. The process begins at the cellular level within the meninges and creates a cascade of effects on normal brain function.

Meningiomas arise from cells called meningeal cells that make up the protective layers covering the brain and spinal cord. The dura mater, which is the outermost and toughest of these three protective layers, is where most meningiomas originate. As a result, these tumors tend to occur along the surface of the brain rather than deep within brain tissue.[3][10]

In malignant meningiomas, genetic mutations cause the meningeal cells to divide rapidly and uncontrollably. These abnormal cells form a mass that grows much faster than benign meningiomas, sometimes at rates of several millimeters per year. As the tumor expands, it creates pressure on the adjacent brain tissue, nerves, and blood vessels.[1]

Unlike benign meningiomas that simply push against the brain, malignant meningiomas can invade surrounding tissue. This means the tumor cells actually penetrate into nearby structures, including bone tissue of the skull and the brain itself. This invasive behavior makes complete surgical removal much more challenging.[3][10]

One particularly concerning feature of malignant meningiomas is their ability to spread. While most meningiomas stay in one place, Grade III tumors can spread through the cerebrospinal fluid, which is the clear liquid that flows around the brain and spinal cord. In rare cases, they may even spread to other organs in the body, though this remains uncommon.[3][10]

The pressure created by the growing tumor disrupts normal brain function in the affected area. Different regions of the brain control different functions, which explains why tumor location determines symptoms. A tumor pressing on the visual cortex affects sight, while one near motor areas affects movement, and so on. The brain has limited space inside the rigid skull, so any mass taking up room creates problems.[1]

Large tumors can block the flow of cerebrospinal fluid, leading to a buildup of pressure inside the skull. This increased intracranial pressure causes headaches, nausea, and can lead to more serious complications if not addressed. The tumor may also compress blood vessels, potentially reducing blood flow to important brain regions.[4]

The rapid growth rate of malignant meningiomas means these effects accumulate more quickly than with benign tumors. Symptoms may worsen over weeks or months rather than years. The tumor’s aggressive behavior and tendency to invade tissue explains why malignant meningiomas often return after treatment and why they require more intensive therapeutic approaches than their benign counterparts.[6]

Ongoing Clinical Trials on Meningioma malignant

References

https://my.clevelandclinic.org/health/diseases/17858-meningioma

https://www.mayoclinic.org/diseases-conditions/meningioma/symptoms-causes/syc-20355643

https://www.cancer.gov/rare-brain-spine-tumor/tumors/meningioma

https://www.brighamandwomens.org/neurosurgery/meningioma

https://braintumor.org/news/lets-talk-about-meningioma/

https://pmc.ncbi.nlm.nih.gov/articles/PMC4027110/

https://www.ncbi.nlm.nih.gov/books/NBK560538/

https://www.abta.org/tumor_types/meningioma/

https://www.mayoclinic.org/diseases-conditions/meningioma/diagnosis-treatment/drc-20355648

https://www.cancer.gov/rare-brain-spine-tumor/tumors/meningioma

https://my.clevelandclinic.org/health/diseases/17858-meningioma

FAQ

How is malignant meningioma different from other meningiomas?

Malignant meningiomas are Grade III tumors that grow rapidly, have irregular cells, and can invade brain tissue or spread to other parts of the body. In contrast, Grade I meningiomas are benign, grow very slowly, and don’t spread. Grade II meningiomas fall in between, growing faster than Grade I but still not being cancerous. Only Grade III is truly malignant.

What is the outlook for someone diagnosed with malignant meningioma?

Malignant meningiomas have a more challenging prognosis than benign forms, with a five-year survival rate ranging from 32 to 64 percent. However, outcomes vary significantly based on factors like whether the tumor can be completely removed surgically, the patient’s age and overall health, and response to treatments like radiation therapy. Recurrence rates are higher with malignant forms, and ongoing monitoring is essential.

Can malignant meningioma be cured with surgery?

Complete surgical removal offers the best chance for controlling malignant meningiomas, but complete cure is challenging because these tumors tend to invade surrounding tissue. About 26.7 percent of patients in one study experienced recurrence even after surgery. Most patients receive radiation therapy after surgery to help control any remaining tumor cells and reduce the chance of recurrence.

Will I need radiation therapy after surgery for malignant meningioma?

Yes, radiation therapy is commonly recommended after surgery for malignant meningiomas. Research shows that about 93.3 percent of patients with malignant meningiomas receive radiotherapy after surgical removal. The combination of aggressive surgery followed by radiation provides better tumor control than surgery alone, especially for these fast-growing cancerous tumors.

How often do malignant meningiomas come back after treatment?

Malignant meningiomas have a relatively high recurrence rate compared to benign forms. Studies show that recurrences were confirmed in about 26.7 percent of patients during follow-up periods, with the median time to recurrence being around 35 months after initial treatment. This is why regular monitoring with MRI scans is essential for years after treatment.

🎯 Key takeaways

  • Malignant meningiomas are rare, representing less than 3% of all meningiomas, but they grow rapidly and can invade surrounding brain tissue
  • Unlike benign meningiomas that are more common in women, malignant forms occur more often in men and typically appear around age 60
  • Radiation exposure to the head, especially during childhood, significantly increases the risk of developing meningiomas later in life
  • Symptoms depend entirely on tumor location and can include headaches, vision changes, hearing loss, seizures, or weakness in limbs
  • Approximately 3,360 people in the United States are living with high-grade meningiomas, making them genuinely rare tumors
  • Treatment typically combines aggressive surgery with radiation therapy, with about 93% of patients receiving radiotherapy after tumor removal
  • The five-year progression-free survival rate is about 53.6%, meaning roughly half of patients remain without tumor growth for five years
  • Recurrence occurs in about one-quarter of patients, typically around 35 months after initial treatment, making long-term monitoring essential